EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review

Evanthia Thomaidou, Eleni Karlafti iD, Matthaios Didagelos iD, Kalliopi Megari iD, Eleni Argiriadou, Karolina Akinosoglou, Daniel Paramythiotis iD, Christos Savopoulos

Viruses · 2024

DOI: 10.3390/v16030455 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2024. Verfasst von Evanthia Thomaidou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Gr…. Hauptthemen laut MEDLINE: COVID-19, Acalculous Cholecystitis, Cholecystitis, Acute, Cholecystitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute acalculous cholecystitis (AAC) represents cholecystitis without gallstones, occurring in approximately 5–10% of all cases of acute cholecystitis in adults. Several risk factors have been recognized, while infectious diseases can be a cause of cholecystitis in otherwise healthy people. Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread worldwide, leading to an unprecedented pandemic. The virus enters cells through the binding of the spike protein to angiotensin-converting enzyme 2 (ACE2) receptors expressed in many human tissues, including the epithelial cells of the gastrointestinal (GI) tract, and this explains the symptoms emanating from the digestive system. Acute cholecystitis has been reported in patients with COVID-19. The purpose of this review is to provide a detailed analysis of the current literature on the pathogenesis, diagnosis, management, and outcomes of AAC in patients with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Acalculous CholecystitisCholecystitis, AcuteCholecystitisAdultHumansSARS-CoV-2Peptidyl-Dipeptidase A

Stichwörter der Autor:innen

COVIDSARS-CoV-2acalculous cholecystitisgallbladder

Substanzen

Peptidyl-Dipeptidase A

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care Unit, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • Emergency Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • First Propaedeutic Internal Medicine Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • 1st Cardiology Department, AHEPA University General Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
  • CITY College, University of York Europe Campus, 54626 Thessaloniki, Greece.
  • Department of Medicine, University General Hospital of Patras, 26504 Rio, Greece.

ORCID-Profile: Eleni Karlafti, Matthaios Didagelos, Kalliopi Megari, Daniel Paramythiotis

Zitieren

APA

Thomaidou, E., Karlafti, E., Didagelos, M., Megari, K., Argiriadou, E., Akinosoglou, K., Paramythiotis, D., & Savopoulos, C. (2024). Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review. Viruses. https://doi.org/10.3390/v16030455

Vancouver

Thomaidou E, Karlafti E, Didagelos M, Megari K, Argiriadou E, Akinosoglou K, et al. Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review. Viruses. 2024. doi:10.3390/v16030455

BibTeX
@article{Thomaidou2024,
  author = {Thomaidou, Evanthia and Karlafti, Eleni and Didagelos, Matthaios and Megari, Kalliopi and Argiriadou, Eleni and Akinosoglou, Karolina and Paramythiotis, Daniel and Savopoulos, Christos},
  title = {Acalculous Cholecystitis in COVID-19 Patients: A Narrative Review},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16030455}
}
Kostenlos starten →